XL4-11614-19836
4 vaccinations
2 coded responses
25 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 993 / WA
- Registered
- 2021-04-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-07
Dose 1 — Moderna
-
2021-04-04
Dose 2 — Moderna
-
2021-04-15
Registered in v-safe
-
2021-04-15
Health check-in — day 7, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-19
- 2021-04-25
- 2021-05-02
- 2021-05-09
- 2021-05-16
- 2021-07-04
- 2021-10-03
-
2021-10-28
Dose 3 — Moderna
-
2021-10-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2021-10-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling, Itching · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-31
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
-
2021-11-01
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling, Itching · Headache, Fatigue or tirednessAdult check-in
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-11
- 2021-11-18
- 2021-11-25
- 2021-12-02
- 2021-12-09
- 2022-01-27
-
2022-04-28
Survey response — 6 months, dose 3MedDRA: Chills, Cough, Dyspnoea, Nasopharyngitis, Oropharyngeal pain, Pain, Pyrexia, SARS-CoV-2 test negative, Viral infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Virus but testing negative for Covid. Fever chills aches head cold bad cough sore throat difficulty breathing On steroid, antibiotic and cough supressantMedDRA releases: 2024-11 · check-in free text available
-
2022-04-28
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-02
-
2022-10-15
Dose 4 — Pfizer-BioNTech
-
2022-10-28
Survey response — 12 months, dose 3MedDRA: COVID-19, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Covid - then tested positive for 23 days - then lasting symptoms continuing now.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-28
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-31
- 2022-10-31
- 2023-01-14
- 2023-04-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-07 | Moderna | |
| 2 | 2021-04-04 | Moderna | |
| 3 | 2021-10-28 | Moderna | No |
| 4 | 2022-10-15 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-28 | Unsuccessful | |
| 2022-10-28 | Unsuccessful |
Free text
Release 11 — 6 months, dose 3
Symptoms: Virus but testing negative for Covid. Fever chills aches head cold bad cough sore throat difficulty breathing On steroid, antibiotic and cough supressant
Release 12 — 12 months, dose 3
Symptoms: Covid - then tested positive for 23 days - then lasting symptoms continuing now.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release